Фибрилляция ва юрак етишмовчилигига замонавий даволашга ёндашувлар (Адабиётлар тахлили)
##semicolon##
бўлмачалар фибрилляцияси##common.commaListSeparator## сурункали юрак етишмовчилиги##common.commaListSeparator## ўлим##common.commaListSeparator## прогнозAnnotatsiya
Бўлмачалар фибрилляцияси (БФ) жиддий касаллик бўлиб, у юқори касаллик ва ўлим хавфи билан боғлиқ. Унинг асосий асоратларидан бири сурункали юрак етишмовчилиги (ЮЕ) ривожланишидир. Бу икки ҳолат бир-бирига ўзаро таъсир кўрсатади, бу эса даволаш стратегиясини танлашда алоҳида ёндашувни талаб қилади. Мақолада БФ ва ЮЕ биргаликда учраган ҳолатларда тарқалиш ва прогноз хусусиятлари ўрганилган. Ушбу касалликларни бошқариш бўйича регистрлар ва мета-таҳлиллар маълумотлари келтирилган. Шунингдек, БФ ва ЮЕ ҳолатида ритмни назорат қилишнинг замонавий усуллари, сўнгги тадқиқот натижалари ва янгиланган клиник тавсиялар асосида таҳлил қилинган
##submission.citations##
1. Wang TJ, Larson MG, Levy D, et al. Temporal relations ofatrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation. 2003;107(23):2920-5. DOI:10.1161/01.CIR.0000072767.89944.6E
2. Santhanakrishnan R, Wang N, Larson MG, et al. Atrial fibrillationbegets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction. Circulation.2016; 133(5):484-92. DOI:10.1161/CIRCULATIONAHA.115.018614
3. Karnik AA, Gopal DM, Ko D, et al. Epidemiology of Atrial Fibrillation and Heart Failure: A Growing and Important Problem. Cardiol Clin. 2019;37(2):119-29. DOI:10.1016/j.ccl.2019.01.001 10. Cha YM, Redfield MM, Shen WK, Gersh BJ. Atrial fibrillation and ventricular dysfunction: a vicious electromechanical cycle. Circulation. 2004;109:2839-43. DOI:10.1161/01.CIR.0000132470.78896.A8
4. Tsigkas G, Apostolos A, Despotopoulos S, et al. Heart failure and atrial fibrillation: new concepts in pathophysiology, management, and future directions. Heart Fail Rev. 2021. DOI:10.1007/s10741-021-10133-6
5. Piccini JP, Hammill BG, Sinner MF, et al. Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke. Eur Heart J. 2014;35(4):250-6. DOI:10.1093/eurheartj/eht483
6. Zafrir B, Lund LH, Laroche C, et al. Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term Registry. Eur Heart J.2018;39:4277-84. DOI:10.1093/eurheartj/ehy626
7. Pandey A, Kim S, Moore C, et al. Predictors and Prognostic Implications of Incident Heart Failure in Patients With Prevalent Atrial Fibrillation.
8. Al Turki A, Proietti R, Dawas A, et al. Catheter ablation for atrial fibrillation in heart failure with reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials. BMC Cardiovasc Disord. 2019;19:18. DOI:10.1186/s12872-019-0998-2
9. Marrouche NF, Brachmann J, Andresen D, et al.; CASTLE-AF Investigators. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med. 2018;378:417-27. DOI:10.1056/NEJMoa1707855
10. Kuck KH, Merkely B, Zahn R, et al. Catheter ablation versus best medical therapy in patients with persistent atrial fibrillation and congestive heart failure: the randomized AMICA trial. Circ Arrhythm Electrophysiol. 2019;12:e007731. DOI:10.1161/CIRCEP.119.007731
11. Packer DL, Piccini JP, Monahan KH et al. Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure: Results From the CABANA Trial. Circulation.2021;143(14):1377-90.
12. Mulder BA, Rienstra M, Gelder IC, Blaauw Y. Update on management of atrial fibrillation in heart failure: a focus on ablation. Heart. 2021;heartjnl-2020-318081. DOI:10.1136/heartjnl-2020-318081.
